Display options
Cite
Rumore MM, Randy Vogenberg F. Biosimilars: Still Not Quite Ready for Prime Time. P T. 2016;41(6):366-75
Rumore, M. M., & Randy Vogenberg, F. (2016). Biosimilars: Still Not Quite Ready for Prime Time. P & T : a peer-reviewed journal for formulary management, 41(6), 366-75.
Rumore, Martha M, and Randy Vogenberg, F. "Biosimilars: Still Not Quite Ready for Prime Time." P & T : a peer-reviewed journal for formulary management vol. 41,6 (2016): 366-75.
Rumore MM, Randy Vogenberg F. Biosimilars: Still Not Quite Ready for Prime Time. P T. 2016 Jun;41(6):366-75. PMID: 27313434; PMCID: PMC4894513.
Copy Download .nbib Format: NLM
Share it on

P T. 2016 Jun;41(6):366-75.

Biosimilars: Still Not Quite Ready for Prime Time.

P & T : a peer-reviewed journal for formulary management

Martha M Rumore, F Randy Vogenberg

PMID: 27313434 PMCID: PMC4894513

Abstract

Biosimilars represent a potential savings opportunity for both payers and patients, but how and when the new agents will be accepted and prescribed is uncertain.

Keywords: 351(k) application; biologics; biosimilars; health benefits; interchangeable; pharmacy practice; substitution

References

  1. Nat Rev Drug Discov. 2014 Feb;13(2):99-100 - PubMed
  2. J Manag Care Spec Pharm. 2015 Jan;21(1):23-34 - PubMed
  3. Am J Health Syst Pharm. 2013 Nov 15;70(22):2004-17 - PubMed
  4. Health Aff (Millwood). 2015 Feb;34(2):294-301 - PubMed
  5. Hosp Pharm. 2014 Oct;49(9):813-25 - PubMed
  6. BioDrugs. 2011 Feb 1;25(1):63-7 - PubMed
  7. Pulm Pharmacol Ther. 2012 Dec;25(6):483-6 - PubMed
  8. Cancer Med. 2014 Aug;3(4):889-99 - PubMed
  9. Am J Law Med. 2015;41(1):49-84 - PubMed
  10. J Natl Compr Canc Netw. 2011 Sep;9 Suppl 4:S1-22 - PubMed
  11. Clin Ther. 2012 Feb;34(2):400-19 - PubMed

Publication Types